Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 17, Issue 12, Pages 1144-1149
Publisher
Springer Nature
Online
2012-04-10
DOI
10.1038/mp.2012.25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials
- (2013) Julian G Martins JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Effect of Omega-3 Fatty Acids Supplementation on Depressive Symptoms and on Health-Related Quality of Life in the Treatment of Elderly Women with Depression: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
- (2013) Mariangela Rondanelli et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
- (2011) M. Elizabeth Sublette et al. JOURNAL OF CLINICAL PSYCHIATRY
- Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed mood
- (2010) Katherine M Appleton et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study
- (2010) M. Bot et al. JOURNAL OF AFFECTIVE DISORDERS
- The Efficacy of Omega-3 Supplementation for Major Depression
- (2010) François Lespérance et al. JOURNAL OF CLINICAL PSYCHIATRY
- Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease
- (2009) Robert M. Carney et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy
- (2009) Kuan-Pin Su et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder
- (2009) David Mischoulon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial
- (2008) Michel Lucas et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder
- (2008) Shima Jazayeri et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Omega-3 Fatty Acids as a Treatment for Perinatal Depression: Randomized Double-Blind Placebo-Controlled Trial
- (2008) Anne-Marie Rees et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Omega-3 fatty acids and supportive psychotherapy for perinatal depression: A randomized placebo-controlled study
- (2008) Marlene P. Freeman et al. JOURNAL OF AFFECTIVE DISORDERS
- Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation
- (2008) Ticyana Moralez da Silva et al. JOURNAL OF AFFECTIVE DISORDERS
- Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
- (2008) Erick H. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started